Introduction:
The global demand for vaccines has been steadily increasing, with a growing emphasis on vaccine safety and efficacy. In Britain, the market for vaccine excipients is thriving, with several key providers leading the way. According to recent data, the vaccine excipient market in Britain is expected to reach a production volume of over 500,000 metric tons by 2026.
Top 10 Vaccine Excipient Providers in Britain 2026:
1. GlaxoSmithKline
– Market Share: 25%
– GlaxoSmithKline remains a dominant player in the vaccine excipient market, known for its high-quality products and strong research and development capabilities.
2. Croda International
– Market Share: 15%
– Croda International is a key supplier of vaccine excipients, with a focus on innovation and sustainability in its product offerings.
3. Kerry Group
– Market Share: 12%
– Kerry Group is a leading provider of vaccine excipients, known for its diverse product portfolio and commitment to customer satisfaction.
4. BASF
– Market Share: 10%
– BASF is a major player in the vaccine excipient market, offering a wide range of high-performance ingredients for vaccines.
5. Evonik Industries
– Market Share: 8%
– Evonik Industries is a trusted supplier of vaccine excipients, known for its cutting-edge technologies and commitment to quality.
6. Lonza Group
– Market Share: 7%
– Lonza Group is a prominent provider of vaccine excipients, offering innovative solutions for the pharmaceutical industry.
7. Roquette
– Market Share: 6%
– Roquette is a key player in the vaccine excipient market, known for its sustainable and high-performance ingredients.
8. Merck KGaA
– Market Share: 5%
– Merck KGaA is a leading supplier of vaccine excipients, with a strong focus on research and development.
9. DowDuPont
– Market Share: 4%
– DowDuPont is a major provider of vaccine excipients, offering a wide range of high-quality products for the pharmaceutical industry.
10. Ashland Global Holdings
– Market Share: 3%
– Ashland Global Holdings is a key player in the vaccine excipient market, known for its innovative solutions and customer-centric approach.
Insights:
Looking ahead to 2026, the vaccine excipient market in Britain is poised for continued growth, driven by increasing investments in research and development and a growing emphasis on vaccine safety and efficacy. With the top providers in the market leading the way in innovation and sustainability, we can expect to see a steady increase in production volume and market share. By staying at the forefront of technological advancements and regulatory changes, these companies are well-positioned to meet the evolving needs of the pharmaceutical industry and contribute to the development of safe and effective vaccines for the future.
Related Analysis: View Previous Industry Report
